Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKION LATER Q2008 spleen study in adult survivors of childhood cancer
NL-OMON47549Active, not recruiting
- Sponsor
- SKion
- Start
- Oct 2017
- Countries
- 1
01
Overview
Open-label trial in hyposplenia and asplenia (3 arms), sponsored by SKion. Primary endpoints: Individual diagnostic value of IgM memory B cells after irradiation over the spleen and Number of hypo- or asplenic patients with vaccine failure. Started Oct 2017; status: active, not recruiting.
02
Conditions
hypospleniaasplenia
Beyond the preview
Go deeper on NL-OMON47549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47549.